American Oncology Network, Inc. Annual Operating Income (Loss) in USD from 2020 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
American Oncology Network, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
  • American Oncology Network, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $8.22M.
  • American Oncology Network, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$17.4M, a 64.5% increase year-over-year.
  • American Oncology Network, Inc. annual Operating Income (Loss) for 2024 was -$17.4M, a 64.5% increase from 2023.
  • American Oncology Network, Inc. annual Operating Income (Loss) for 2023 was -$49.2M, a 983% decline from 2022.
  • American Oncology Network, Inc. annual Operating Income (Loss) for 2022 was $5.57M, a 511% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$17.4M +$31.7M +64.5% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-27
2023 -$49.2M -$54.7M -983% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-27
2022 $5.57M +$4.66M +511% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $911K -$21.2M -95.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 $22.1M Jan 1, 2020 Dec 31, 2020 8-K 2023-11-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.